Fostamatinib disodium and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fostamatinib disodium and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fostamatinib
Brand name: Tavalisse
Synonyms: Fostamatinib disodium (Oral)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fostamatinib disodium-Insulin degludec
- Fostamatinib disodium-Insulin Degludec (U-100) Prefilled Pens
- Fostamatinib disodium-Insulin Degludec (U-100) Vials
- Fostamatinib disodium-Insulin Degludec (U-200) Prefilled Pens
- Fostamatinib disodium-Insulin degludec and liraglutide
- Fostamatinib disodium-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fosteum
- Insulin aspart, recombinant Subcutaneous-Fostex
- Insulin aspart, recombinant Subcutaneous-Fostex Cream Topical
- Insulin aspart, recombinant Subcutaneous-Fostex Medicated
- Insulin aspart, recombinant Subcutaneous-Fostex Wash 10%
- Insulin aspart, recombinant Subcutaneous-Fototar